论文部分内容阅读
麦迪霉素自从70年代末应用手我国临床以来,由于它对革兰氏阳性菌抗菌活性强,口服易吸收,使用方便,安全有效,一直深受广大患者的青睐,并逐步成为我国常用的抗生素之一.通过十几年的临床验证,发现国产“麦迪霉素”与进口“麦迪霉素”有临床差异.后经中国药品生物制品检定所进行组份确证,国产“麦迪霉素”的成份确实与进口“麦迪霉素”不同。国产“麦迪霉素”实为麦迪霉素 A_1与柱晶白霉素等多组份的混合物。因此,为了临床医生用药的准确
Midecamycin has been favored by patients since its application to clinical practice in our country since the late 1970s due to its strong antibacterial activity against gram-positive bacteria, oral absorption, ease of use, safety and efficacy, and has gradually become popular antibiotics in our country One through more than 10 years of clinical validation and found that domestic “midecamycin” and imported “midecamycin” there are clinical differences.After the Chinese medicine and biological products for the confirmation of components, domestic “midecamycin” component Indeed different from the import of “midecamycin.” Domestic “midecamycin” really Magensomycin A_1 with leucomycin and other components of the mixture. Therefore, in order to clinicians accurate medication